Hamilton-Craig I - Search Results

1

A topographical map of the causal network of mechanisms underlying the relationship between major depressive disorder and coronary heart disease.

Stapelberg NJ, Neumann DL, Shum DH, McConnell H, Hamilton-Craig I. Stapelberg NJ, et al. Aust N Z J Psychiatry. 2011 May;45(5):351-69. doi: 10.3109/00048674.2011.570427. Aust N Z J Psychiatry. 2011. PMID: 21500954 Review.

2

Mind and heart: heart rate variability in major depressive disorder and coronary heart disease - a review and recommendations.

Stapelberg NJ, Hamilton-Craig I, Neumann DL, Shum DH, McConnell H. Stapelberg NJ, et al. Aust N Z J Psychiatry. 2012 Oct;46(10):946-57. doi: 10.1177/0004867412444624. Epub 2012 Apr 23. Aust N Z J Psychiatry. 2012. PMID: 22528974 Review.

3

A preprocessing tool for removing artifact from cardiac RR interval recordings using three-dimensional spatial distribution mapping.

Stapelberg NJ, Neumann DL, Shum DH, McConnell H, Hamilton-Craig I. Stapelberg NJ, et al. Among authors: hamilton craig i. Psychophysiology. 2016 Apr;53(4):482-92. doi: 10.1111/psyp.12598. Epub 2016 Jan 11. Psychophysiology. 2016. PMID: 26751605

4

The sensitivity of 38 heart rate variability measures to the addition of artifact in human and artificial 24-hr cardiac recordings.

Stapelberg NJC, Neumann DL, Shum DHK, McConnell H, Hamilton-Craig I. Stapelberg NJC, et al. Among authors: hamilton craig i. Ann Noninvasive Electrocardiol. 2018 Jan;23(1):e12483. doi: 10.1111/anec.12483. Epub 2017 Jul 2. Ann Noninvasive Electrocardiol. 2018. PMID: 28670841 Free PMC article.

5

Heart rate and use of beta-blockers in stable outpatients with coronary artery disease.

Steg PG, Ferrari R, Ford I, Greenlaw N, Tardif JC, Tendera M, Abergel H, Fox KM; CLARIFY Investigators. Steg PG, et al. PLoS One. 2012;7(5):e36284. doi: 10.1371/journal.pone.0036284. Epub 2012 May 3. PLoS One. 2012. PMID: 22570699 Free PMC article.

6

Prescribing statins: the real issues.

Hamilton-Craig IR. Hamilton-Craig IR. Med J Aust. 2014 May 5;200(8):440-1. doi: 10.5694/mja13.00039. Med J Aust. 2014. PMID: 24794593 No abstract available.

7

Use of fibrates in clinical practice: Queensland Lipid Group consensus recommendations.

Hamilton-Craig I, Kostner KM, Woodhouse S, Colquhoun D. Hamilton-Craig I, et al. Int J Evid Based Healthc. 2012 Sep;10(3):181-90. doi: 10.1111/j.1744-1609.2012.00275.x. Int J Evid Based Healthc. 2012. PMID: 22925614

8

At sea with SEAS: the first clinical endpoint trial for ezetimibe, treatment of patients with mild to moderate aortic stenosis, ends with mixed results and more controversy.

Hamilton-Craig I, Kostner K, Colquhoun D, Woodhouse S. Hamilton-Craig I, et al. Heart Lung Circ. 2009 Oct;18(5):343-6. doi: 10.1016/j.hlc.2009.02.007. Epub 2009 Jul 7. Heart Lung Circ. 2009. PMID: 19586799

9

Fenofibrate therapy in carnitine palmitoyl transferase type 2 deficiency.

Hamilton-Craig I, Yudi M, Johnson L, Jayasinghe R. Hamilton-Craig I, et al. Case Rep Med. 2012;2012:163173. doi: 10.1155/2012/163173. Epub 2012 Dec 3. Case Rep Med. 2012. PMID: 23326270 Free PMC article.

10

Combination therapy of statin and ezetimibe for the treatment of familial hypercholesterolemia.

Hamilton-Craig I, Kostner K, Colquhoun D, Woodhouse S. Hamilton-Craig I, et al. Vasc Health Risk Manag. 2010 Nov 10;6:1023-37. doi: 10.2147/VHRM.S13496. Vasc Health Risk Manag. 2010. PMID: 21127699 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

44 results

Search Page

Filters